Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab with Vinorelbine or Taxane in HER2+ Metastatic Breast Cancer
NCT00146549Phase 3Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Aug 2001
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of vinorelbine in breast cancer (2 arms), sponsored by Dana-Farber Cancer Institute. Primary endpoint: Overall Response Rate. Started Aug 2001; status: completed.
02
Drugs
vinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00146549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00146549.